Key result
Closed-loop transcutaneous auricular vagal nerve stimulation is an emerging neuromodulation modality with existing motor- and respiratory-gated systems and future potential for EEG-, ECG-, and humoral-gated applications.
Why the study?
Closed-loop transcutaneous auricular vagal nerve stimulation was officially proposed in 2020, prompting a need to review existing forms and outline future systems.
Answers are grounded in this paper and cite their sources.
This perspective outlines the current state of closed-loop transcutaneous auricular vagal nerve stimulation and proposes future disease-oriented systems, including ECG-gated modalities for cardiovascular conditions.
Closed-loop (CL) transcutaneous auricular vagal nerve stimulation (taVNS) was officially proposed in 2020. This work firstly reviewed two existing CL-taVNS forms: motor-activated auricular vagus nerve stimulation (MAAVNS) and respiratory-gated auricular vagal afferent nerve stimulation (RAVANS), and then proposed three future CL-taVNS systems: electroencephalography (EEG)-gated CL-taVNS, electrocardiography (ECG)-gated CL-taVNS, and subcutaneous humoral signals (SHS)-gated CL-taVNS. We also highlighted the mechanisms, targets, technical issues, and patterns of CL-taVNS. By reviewing, proposing, and highlighting, this work might draw a preliminary blueprint for the development of CL-taVNS.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2022) conducted a review in Various (Neurological, Cardiovascular, Metabolic). Closed-loop transcutaneous auricular vagal nerve stimulation (CL-taVNS) was evaluated. Closed-loop transcutaneous auricular vagal nerve stimulation is an emerging neuromodulation modality with existing motor- and respiratory-gated systems and future potential for EEG-, ECG-, and humoral-gated applications.
Synapse has enriched 10 related papers. Consider them for comparative context: